Skip to main content
JAMA Network logoLink to JAMA Network
. 2020 Mar 3;3(3):e200306. doi: 10.1001/jamanetworkopen.2020.0306

Assessment of an Algorithm for Prescription of Oral Anticoagulation for Patients With Atrial Fibrillation in Emergency Departments

Clare L Atzema 1,2,3,4,, Jiming Fang 1, Jafna L Cox 5,6, Alice S Chong 1, Karen Tu 4,7,8, Peter C Austin 1,2,4
PMCID: PMC7054828  PMID: 32125425

Abstract

This retrospective study uses a Canadian reporting system to validate an algorithm that identifies oral anticoagulation prescriptions given to patients with atrial fibrillation treated in emergency departments.

Introduction

Atrial fibrillation is seen commonly in emergency departments (EDs).1,2 Initiation of oral anticoagulation to patients treated in the ED has been associated with higher long-term use than when prescribing is left to outpatient care following discharge.3

Current data sets do not identify ED prescriptions. The ability to identify these prescriptions in large data sets could facilitate future studies aimed at increasing such prescriptions and could support long-term monitoring of ED oral anticoagulant prescription patterns.

Methods

This retrospective cohort study sought to validate an algorithm that identifies ED oral anticoagulant prescription provision for patients with atrial fibrillation using administrative health data sets. Using the National Ambulatory Care Reporting System,4 we identified patients who had visited 1 of 20 Ontario EDs with a primary diagnosis of atrial fibrillation, in the years 2009 through 2014. We excluded patients who would not benefit from5 or who had been taking oral anticoagulant agents within 90 days, were younger than 65 years (because we do not have comprehensive outpatient medication data for them), or had been admitted to the hospital. Data were abstracted from patient medical records for the first visit per patient. Using unique encoded identifiers, we linked the medical record data to databases held at ICES. The study was approved by the Research Ethics Board of Sunnybrook Health Sciences Centre. This report follows the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.

The reference standard was medical record documentation of provision of an oral anticoagulant prescription by any physician (emergency or consultant). Thirty-two algorithms selected a priori were tested. We varied the algorithms in the following ways: (1) including oral anticoagulant prescription fills that occurred on the same day (day 0) as the patient left the ED (because some patients are sent to the ED by another clinician who may have prescribed the agent); (2) counting the number of days following discharge that patients filled a prescription; (3) excluding prescription fills that occurred after an outpatient visit with a relevant clinician (because that clinician may have written the prescription being filled); (4) excluding patients with a history of venous thromboembolism; and (5) removing patients who had seen a relevant clinician 30 days prior to the emergency visit. We calculated the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), and 95% (CIs). All analyses were conducted with SAS statistical software version 9.3 (SAS Institute Inc).

Results

Of 2015 qualifying patients, 65% had a CHADS2 (congestive heart failure, hypertension, age >75 years, diabetes, and stroke) score of 2 or higher. Emergency department physicians prescribed warfarin for a median of 7 days and oral anticoagulant agents for a median of 30 days. Inclusion of day 0 substantially improved sensitivity, eg, 34% of patients analyzed in algorithm 3, prescriptions filled between days 1 and 3, to 83% of patients analyzed in algorithm 2, prescriptions filled between days 0 and 3 (Table 1). Using a longer follow-up period for prescription fills lowered specificity (91% in algorithm 2 to 74% in algorithm 10, prescriptions filled between days 0 and 30, and only slightly improved sensitivity (83% to 88%).

Table 1. Algorithm Test Characteristics Among Patients Treated in the Emergency Department.

Algorithm No. Days in Which Oral Anticoagulant Prescription Filled True Positive True Negative False Positive False Negative Sensitivity
(95% CI)
Specificity
(95% CI)
Positive Predictive Value
(95% CI)
Negative Predictive Value
(95% CI)
Rate, %
Filled
1 0 198 1576 36 205 0.491 (0.442-0.540) 0.978 (0.971-0.985) 0.846 (0.800-0.892) 0.885 (0.870-0.900) 11.6
2 0-3 335 1466 146 68 0.831 (0.794-0.868) 0.909 (0.895-0.923) 0.696 (0.655-0.737) 0.956 (0.946-0.966) 23.9
3 1-3 137 1502 110 266 0.340 (0.294-0.386) 0.932 (0.920-0.944) 0.555 (0.493-0.617) 0.850 (0.833-0.867) 12.3
4 0-4 338 1441 171 65 0.839 (0.803-0.875) 0.894 (0.879-0.909) 0.664 (0.623-0.705) 0.957 (0.947-0.967) 25.3
5 1-4 140 1477 135 263 0.347 (0.301-0.393) 0.916 (0.902-0.930) 0.509 (0.450-0.568) 0.849 (0.832-0.866) 13.7
6 0-7 346 1374 238 57 0.859 (0.825-0.893) 0.852 (0.835-0.869) 0.592 (0.552-0.632) 0.960 (0.950-0.970) 29.0
7 1-7 148 1410 202 255 0.367 (0.320-0.414) 0.875 (0.859-0.891) 0.423 (0.371-0.475) 0.847 (0.830-0.864) 17.4
8 0-14 350 1297 315 53 0.868 (0.835-0.901) 0.805 (0.786-0.824) 0.526 (0.488-0.564) 0.961 (0.951-0.971) 33.0
9 1-14 152 1333 279 251 0.377 (0.330-0.424) 0.827 (0.809-0.845) 0.353 (0.308-0.398) 0.842 (0.824-0.860) 21.4
10 0-30 356 1189 423 47 0.883 (0.852-0.914) 0.738 (0.717-0.759) 0.457 (0.422-0.492) 0.962 (0.951-0.973) 38.7
11 1-30 158 1225 387 245 0.392 (0.344-0.440) 0.760 (0.739-0.781) 0.290 (0.252-0.328) 0.833 (0.814-0.852) 27.1
Filled Prior to Any Appointment With a Family Physician, Cardiologist, or Internist
12 0-14 264 1560 52 139 0.655 (0.609-0.701) 0.968 (0.959-0.977) 0.835 (0.794-0.876) 0.918 (0.905-0.931) 15.7
13 0-30 272 1557 55 131 0.675 (0.629-0.721) 0.966 (0.957-0.975) 0.832 (0.791-0.873) 0.922 (0.909-0.935) 16.2
14 0-30a 272 1557 55 131 0.675 (0.629-0.721) 0.966 (0.957-0.975) 0.832 (0.791-0.873) 0.922 (0.909-0.935) 16.2
Filled Prior to Any Appointment With a Family Physician, Cardiologist, or Internist and Had No Appointments 30 d Prior to ED Visit
15 0-30 98 1597 15 305 0.243 (0.201-0.285) 0.991 (0.986-0.996) 0.867 (0.804-0.930) 0.840 (0.824-0.856) 5.6
Filled Prior to Any Appointment With Their Family Physician, Cardiologist, or Internist
16 0-30 236 1567 45 167 0.586 (0.538-0.634) 0.972 (0.964-0.980) 0.840 (0.797-0.883) 0.904 (0.890-0.918) 14.0

Abbreviation: ED, emergency department.

a

Includes a nephrologist.

After restricting to patients who filled a prescription before they saw another clinician, the number of false-positive results (ie, prescriptions filled that were not written in the ED) decreased. Thus, specificity improved from 74% in algorithm 10 to 97% in algorithm 13; however, sensitivity fell from 88% to 68%. Removal of patients with an outpatient visit prior to the ED visit (eg, algorithm 15) further increased specificity (99%) but decreased sensitivity (24%). Excluding patients with a prior venous thromboembolism resulted in minimal change (Table 2).

Table 2. Algorithm Test Characteristics Among Patients Treated in the Emergency Department With No Venous Thromboembolism Diagnosis in the Previous 5 Years.

Algorithm No. Days in Which Oral Anticoagulant Prescription Filled True- Positive True Negative False Positive False Negative Sensitivity
(95% CI)
Specificity
(95% CI)
Positive Predictive Value
(95% CI)
Negative Predictive Value
(95% CI)
Rate, %
Filled
17 0 194 1524 35 197 0.496 (0.446-0.546) 0.978 (0.971-0.985) 0.847 (0.800-0.894) 0.886 (0.871-0.901) 11.7
18 0-3 325 1418 141 66 0.831 (0.794-0.868) 0.910 (0.896-0.924) 0.697 (0.655-0.739) 0.956 (0.946-0.966) 23.9
19 1-3 131 1453 106 260 0.335 (0.288-0.382) 0.932 (0.920-0.944) 0.553 (0.490-0.616) 0.848 (0.831-0.865) 12.2
20 0-4 328 1394 165 63 0.839 (0.803-0.875) 0.894 (0.879-0.909) 0.665 (0.623-0.707) 0.957 (0.947-0.967) 25.3
21 1-4 134 1429 130 257 0.343 (0.296-0.390) 0.917 (0.903-0.931) 0.508 (0.448-0.568) 0.848 (0.831-0.865) 13.5
22 0-7 336 1329 230 55 0.859 (0.825-0.893) 0.852 (0.834-0.870) 0.594 (0.554-0.634) 0.960 (0.950-0.970) 29.0
23 1-7 142 1364 195 249 0.363 (0.315-0.411) 0.875 (0.859-0.891) 0.421 (0.368-0.474) 0.846 (0.828-0.864) 17.3
24 0-14 340 1255 304 51 0.870 (0.837-0.903) 0.805 (0.785-0.825) 0.528 (0.489-0.567) 0.961 (0.951-0.971) 33.0
25 1-14 146 1290 269 245 0.373 (0.325-0.421) 0.827 (0.808-0.846) 0.352 (0.306-0.398) 0.840 (0.822-0.858) 21.3
26 0-30 346 1150 409 45 0.885 (0.853-0.917) 0.738 (0.716-0.760) 0.458 (0.422-0.494) 0.962 (0.951-0.973) 38.7
27 1-30 152 1185 374 239 0.389 (0.341-0.437) 0.760 (0.739-0.781) 0.289 (0.250-0.328) 0.832 (0.813-0.851) 27.0
Filled Prior to Any Appointment With a Family Physician, Cardiologist, or Internist
28 0-14 257 1508 51 134 0.657 (0.610-0.704) 0.967 (0.958-0.976) 0.834 (0.792-0.876) 0.918 (0.905-0.931) 15.8
29 0-30 265 1505 54 126 0.678 (0.632-0.724) 0.965 (0.956-0.974) 0.831 (0.790-0.872) 0.923 (0.910-0.936) 16.4
30 0-30a 265 1505 54 126 0.678 (0.632-0.724) 0.965 (0.956-0.974) 0.831 (0.790-0.872) 0.923 (0.910-0.936) 16.4
Filled Prior to Any Appointment With a Family Physician, Cardiologist, or Internist and Had No Appointments 30 d Prior to ED Visit
31 0-30 95 1544 15 296 0.243 (0.200-0.286) 0.990 (0.985-0.995) 0.864 (0.800-0.928) 0.839 (0.822-0.856) 5.6
Filled Prior to Any Appointment With Their Family Physician, Cardiologist, or Internist
32 0-30 229 1515 44 162 0.586 (0.537-0.635) 0.972 (0.964-0.980) 0.839 (0.795-0.883) 0.903 (0.889-0.917) 14.0

Abbreviation: ED, emergency department.

a

Includes a nephrologist.

Algorithm 2 maximized specificity (91%; 95% CI, 90%-92%) while maintaining reasonable sensitivity (83%; 95% CI, 79%-87%) (PPV, 70%; 95% CI, 66%-74%, NPV, 96%; 95% CI, 95%-97%). Algorithm 13, prescription filled prior to seeing another relevant clinician, provided high specificity (97%; 95% CI, 96%-98%).

Limitations include using medical record documentation of ED prescription provision as reference standard, and our results may not apply to patients younger than 65 years.

We derived several algorithms that identify ED oral anticoagulant prescriptions in a large health data set. Depending on project goals, an algorithm can be selected to optimize specificity, sensitivity, PPV, or NPV.

References

  • 1.Atzema CL, Austin PC, Miller E, Chong AS, Yun L, Dorian P. A population-based description of atrial fibrillation in the emergency department, 2002 to 2010. Ann Emerg Med. 2013;62(6):-. doi: 10.1016/j.annemergmed.2013.06.005 [DOI] [PubMed] [Google Scholar]
  • 2.McDonald AJ, Pelletier AJ, Ellinor PT, Camargo CA Jr. Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004. Ann Emerg Med. 2008;51(1):58-65. doi: 10.1016/j.annemergmed.2007.03.007 [DOI] [PubMed] [Google Scholar]
  • 3.Atzema CL, Jackevicius CA, Chong A, et al. Prescribing of oral anticoagulants in the emergency department and subsequent long-term use by older adults with atrial fibrillation. CMAJ. 2019;191(49):E1345-E1354. doi: 10.1503/cmaj.190747 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Canadian Institute for Health Information National Ambulatory Care Reporting System (NACRS) metadata. https://www.cihi.ca/en/types-of-care/hospital-care/emergency-and-ambulatory-care/nacrs-metadata. Published 2019. Accessed November 22, 2019.
  • 5.Skanes AC, Healey JS, Cairns JA, et al. ; Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee . Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol. 2012;28(2):125-136. doi: 10.1016/j.cjca.2012.01.021 [DOI] [PubMed] [Google Scholar]

Articles from JAMA Network Open are provided here courtesy of American Medical Association

RESOURCES